Related references
Note: Only part of the references are listed.The Pathophysiology of the Peritoneal Membrane
Olivier Devuyst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats
Anneleen Pletinck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy
Michele Rossini et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
INDUCTION OF CHRONIC KIDNEY FAILURE IN A LONG-TERM PERITONEAL EXPOSURE MODEL IN THE RAT: EFFECTS ON FUNCTIONAL AND STRUCTURAL PERITONEAL ALTERATIONS
Francois Vrtovsnik et al.
PERITONEAL DIALYSIS INTERNATIONAL (2010)
PERITONEAL INFLAMMATION AFTER TWENTY-WEEK EXPOSURE TO DIALYSIS SOLUTION: EFFECT OF SOLUTION VERSUS CATHETER-FOREIGN BODY REACTION
Michael F. Flessner et al.
PERITONEAL DIALYSIS INTERNATIONAL (2010)
Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity
Marta Ciszewicz et al.
TRANSLATIONAL RESEARCH (2009)
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria
Hiddo Lambers Heerspink et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Anti-inflammatory effect of sulodexide during acute peritonitis in rats
Jacek Karon et al.
BLOOD PURIFICATION (2007)
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
T. M. H. Niers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
The role of sulodexide in the treatment of diabetic nephropathy
Ram Weiss et al.
DRUGS (2007)
Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention
Malgorzata Pyda et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease
V Farooq et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane
S Mortier et al.
KIDNEY INTERNATIONAL (2004)
Effect of haluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells
A Breborowicz et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients
JA Sjoland et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Experimental diabetes induces functional and structural changes in the peritoneum
MS Stoenoiu et al.
KIDNEY INTERNATIONAL (2002)
Sulodexide in the treatment of intermittent claudication - Results of a randomized, double-blind, multicentre, placebo-controlled study
S Coccheri et al.
EUROPEAN HEART JOURNAL (2002)
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type I and type 2 diabetic patients:: The Di.NAS randomized trial
G Gambaro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-β1 gene activation
C Weigert et al.
KIDNEY INTERNATIONAL (2001)
Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis
K Pawlaczyk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)